Small Molecules
8 May 2018
Lynparza tablets receive EU approval for the treatment of platinum-sensitive relapsed ovarian cancer7 May 2018
Foamix Announces Dosing of Last Patient in Third Phase 3 Acne Study for Minocycline Foam FMX1011 May 2018
BioCryst Receives European Medicines Agency Approval for ALPIVAB™ for the Treatment of Influenza28 April 2018
Tagrisso receives positive EU CHMP opinion for 1st-line treatment of EGFR-mutated non-small cell lung cancer28 April 2018
European CHMP Adopts Positive Opinion for Gilead’s Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide)28 April 2018
INSYS Therapeutics Initiates Phase 2 Clinical Trial of Cannabidiol (CBD) for Treatment of Prader-Willi Syndrome27 April 2018
Immunic Reports Start of Enrollment into Clinical Phase 2 Study with IMU-838 in Patients with Ulcerative Colitis27 April 2018
Lupus Research Alliance and Lupus Therapeutics Collaborate with Bristol-Myers Squibb on a New Lupus Trial27 April 2018
Neuraltus Pharmaceuticals Reports Results from Phase 2 NP001 Study in Amyotrophic Lateral Sclerosis (ALS)News Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports